Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Global GLP Balance Sheet Review Global Partners LP posts 109 EPS miss on weak margins Alarmcom ALRM Market Performance Q4 2025 EPS Tops Views Hesai HSAI Stock Entry Signals Risk Aversion 20260418 Atea Pharma AVIR Stock Worthwhile Investment 070 20260418 WDS Woodside Energy Group Limited American Depositary Shares posts 338 percent Q4 2025 EPS beat alongside slight yearoveryear revenue decline KRNY Kearny Financial Corp climbs 253 percent despite reporting a 16 percent Q1 2026 EPS miss against analyst estimates Skeena SKE Trading Strategy Q4 2025 EPS Misses Views GoHealth GOCO Stock Risk Q4 2025 EPS Misses Estimates Is Ladder Capital LADR stock approaching trendline support Q4 2025 EPS Misses Views Mexco MXC Stock Swing Trade Setup 033 20260416 Novanta NOVTU Stock Is It Overvalued Novanta posts 14 EPS beat vs analyst consensus Why Medical MPT Stock Matters Investors Pile In 20260420 JPMorgan Chase Co JPM Persian Gulf Supply Disruptions to Drive Sustained Oil Price Upside Weigh on Asian Economic Growth National NHPBP Stock Shows Strength Eye on Rally 20260420 IGC Pharma IGC Stock Why Competitive Advantage Slight Downtick 20260422 MetLife MET Stock Breakout or Breakdown Institutional Selling 20260420 Is Brandywine BDN stock priced below intrinsic value Q1 2026 Earnings Beat Estimates Is Universal UHT stock gaining strength XTNT Xtant tops Q4 2025 EPS expectations posts 142 percent year over year revenue growth shares rise 7 percent DEA Easterly Gov falls 128 on Q4 EPS miss despite 113 year over year revenue growth What is the sentiment on INmune Bio INMB stock today Institutional Selling 20260420 NAMSW NewAmsterdam does not disclose core quarterly earnings metrics as investors await further operational guidance details CreativeMed CELZ Volatility Analysis Q3 2025 Profit Surprises InfuSystems Holdings INFU Stock Sell Signals Slight Rise 20260420 CAMT Camtek shares rise 288 as Q4 2025 revenue grows 156 despite a slight EPS miss Lucid Group LCID Valuation Assessment Weighing Macro Tailwinds Strategic Backing and Cash Burn Risks at 725 Per Share What interest rate risk AC Immune ACIU Investors Pile In 20260427 What are the risks of Artivion AORT stock today Artivion Logs 40 EPS Miss Below Analyst Estimates